No, a spacer cannot be used with Anoro Ellipta
Anoro Ellipta is a dry powder inhaler (DPI) that is incompatible with spacer devices. Spacers are specifically designed for use with pressurized metered-dose inhalers (pMDIs), not dry powder inhalers 1.
Why Spacers Don't Work with Anoro Ellipta
The Ellipta device delivers medication through a fundamentally different mechanism than pMDIs:
- DPIs require rapid, forceful inhalation (approximately 60 L/min) to disperse the powder from the blister strips and deliver the medication to the lungs 2, 1
- Spacers work with pMDIs that use propellant to aerosolize medication, where the spacer acts as a holding chamber to reduce the need for hand-breath coordination 2
- The Ellipta device contains two foil blister strips with powder that must be activated by the patient's inspiratory flow—adding a spacer would completely disrupt this mechanism 1
Device-Specific Technique for Anoro Ellipta
The FDA label clearly describes that Anoro Ellipta:
- Delivers 55 mcg umeclidinium and 22 mcg vilanterol when tested at 60 L/min flow rate 1
- Requires the patient to inhale directly through the mouthpiece to create the airstream that disperses the powder 1
- Studies show patients with severe COPD achieve mean peak inspiratory flows of 66.5 L/min through the Ellipta device (range 43.5-81.0 L/min), which is adequate for drug delivery 1
Common Pitfall to Avoid
Do not attempt to attach any spacer or valved holding chamber to the Ellipta inhaler. The guidelines explicitly state that breath-actuated MDIs "cannot be used with currently available spacer/VHC devices" 2, and this applies even more critically to DPIs like the Ellipta, which have a completely different delivery mechanism requiring direct inhalation through the device.
If a patient cannot generate adequate inspiratory flow for a DPI, consider switching to a pMDI with spacer or nebulizer rather than attempting to modify the Ellipta device 2.